Published in J Virol on November 01, 1994
Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol (2012) 1.89
Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs. Med Microbiol Immunol (2011) 1.22
Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J Virol (2000) 1.14
Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus. J Clin Microbiol (1999) 1.08
Current Knowledge on Hepatitis E. J Clin Transl Hepatol (2015) 0.89
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal Biochem (1981) 15.38
Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology (1991) 6.38
Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene (1988) 4.14
Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A (1992) 3.24
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06
Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology (1992) 2.92
Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A (1992) 2.64
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J Exp Med (1990) 2.58
Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18
Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet (1992) 2.14
Hepatitis E virus: identification of type-common epitopes. J Virol (1991) 1.95
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods (1992) 1.85
Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol (1992) 1.66
Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol (1993) 1.32
Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes (1993) 1.30
Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res (1989) 1.29
Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis. Proc Natl Acad Sci U S A (1992) 1.26
Epitope mapping in proteins of hepatitis E virus. Virology (1993) 1.25
Hepatitis E virus: the cause of a waterbourne hepatitis outbreak. J Med Virol (1992) 1.24
Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology (1994) 1.22
Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol (1992) 1.18
Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A (1992) 1.08
Hepatitis E virus (HEV): the novel agent responsible for enterically transmitted non-A, non-B hepatitis. Gastroenterol Jpn (1991) 0.99
Mapping of linear B cell epitopes on open reading frames 2- and 3-encoded proteins of hepatitis E virus using synthetic peptides. FEMS Microbiol Lett (1993) 0.98
Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays. Lancet (1992) 0.96
Immunoelectron microscopic localization of herpes simplex virus glycoprotein gB in the nuclear envelope of infected cells. Virus Res (1993) 0.95
A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of hepatitis B surface antigen. J Immunol (1992) 0.90
Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides. J Virol Methods (1994) 0.86
Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins. J Virol (1993) 0.85
Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J Med Virol (1993) 0.84
Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus. J Gen Virol (1994) 0.83
Cloning and expression of cDNAs from enterically-transmitted non-A, non-B hepatitis virus. Microbiol Immunol (1991) 0.77
Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med (1996) 4.71
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89
Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol (1992) 3.81
Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health (1999) 3.55
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA (1990) 3.41
Characterisation of a newly identified human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis. J Clin Virol (2007) 3.11
Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis (1998) 2.67
A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA. J Clin Microbiol (1997) 2.46
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med (1989) 2.30
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus. J Med Virol (1987) 1.89
Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay. J Clin Microbiol (1977) 1.80
Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis (1997) 1.79
Emerging respiratory agents: new viruses for old diseases? J Clin Virol (2008) 1.78
Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J Virol (1984) 1.75
Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis (2001) 1.73
Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCR. J Clin Microbiol (1998) 1.71
Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection. J Clin Virol (2008) 1.68
Molecular cloning and characterization of the structural gene for the major iron-regulated protein expressed by Neisseria gonorrhoeae. J Exp Med (1990) 1.68
Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol (1992) 1.66
Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J Clin Microbiol (1995) 1.65
Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol (1979) 1.64
Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus. J Clin Microbiol (1979) 1.60
Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J Clin Microbiol (1999) 1.56
Molecular cloning and sequencing of the La Crosse virus S RNA. Virology (1983) 1.50
Towards understanding the evolution of the human commensal yeast Candida albicans. Microbiology (1999) 1.49
Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol (2000) 1.46
Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections? J Clin Virol (2009) 1.44
Nonhemolytic Listeria monocytogenes mutants that are also noninvasive for mammalian cells in culture: evidence for coordinate regulation of virulence. Infect Immun (1990) 1.43
The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. Virology (1989) 1.42
Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg (1995) 1.39
Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology (2001) 1.39
Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus. J Clin Microbiol (1998) 1.36
The structural proteins of rabies virus and evidence for their synthesis from separate monocistronic RNA species. J Gen Virol (1980) 1.35
Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology (1996) 1.34
Nucleotide sequence of htpB, the Legionella pneumophila gene encoding the 58-kilodalton (kDa) common antigen, formerly designated the 60-kDa common antigen. Infect Immun (1990) 1.33
Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003. J Clin Virol (2010) 1.33
Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol (2001) 1.32
Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis (1983) 1.32
Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells. J Clin Microbiol (1986) 1.29
Epitope mapping in proteins of hepatitis E virus. Virology (1993) 1.25
Lethal outbreak of hepatitis B in a dental practice. JAMA (1986) 1.24
Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology (1994) 1.22
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc Natl Acad Sci U S A (1999) 1.19
Development and evaluation of real-time PCR assays for the detection of the newly identified KI and WU polyomaviruses. J Clin Virol (2007) 1.19
Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol (2001) 1.15
Measles immunity among young adults in Victoria. Commun Dis Intell Q Rep (2001) 1.14
False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011. Euro Surveill (2011) 1.13
IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol (1996) 1.12
Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med (1987) 1.11
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol (1998) 1.10
Replication kinetics and cytopathic effect of hepatitis A virus. J Gen Virol (1989) 1.10
Multiple leader RNAs and messenger RNAs are transcribed from the La Crosse virus small genome segment. Cell (1983) 1.10
Human coronavirus OC43 causes influenza-like illness in residents and staff of aged-care facilities in Melbourne, Australia. Epidemiol Infect (2005) 1.09
Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus. J Clin Microbiol (1999) 1.08
Purification and characterization of a pilin specific for Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius (H. aegyptius) strains. J Clin Microbiol (1990) 1.08
Structure of the hepatitis A virion: peptide mapping of the capsid region. J Virol (1986) 1.08
Aetiology of acute sporadic non-A, non-B viral hepatitis in India. J Med Virol (1993) 1.08
Sequence heterogeneity of TT virus and closely related viruses. J Virol (2000) 1.04
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A. Am J Public Health (1990) 1.03
Experimental hepatic porphyria induced by polychlorinated biphenyls. Toxicol Appl Pharmacol (1974) 1.02
Detection of hepatitis C virus core protein circulating within different virus particle populations. J Med Virol (1998) 1.00
Real-time PCR-based fluorescent assay for quantitation of human papillomavirus types 6, 11, 16, and 18. Mol Diagn (2001) 1.00
Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains. J Med Virol (1984) 1.00
Progress toward tuberculosis control and determinants of treatment outcomes--Kazakhstan, 2000-2002. MMWR Morb Mortal Wkly Rep (2006) 0.99
Rapid confirmation of Listeria monocytogenes isolated from foods by a colony blot assay using a digoxigenin-labeled synthetic oligonucleotide probe. Appl Environ Microbiol (1991) 0.99
A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine (2012) 0.98
Rabies virus-induced RNA synthesis in BHK21 cells. J Gen Virol (1980) 0.98
Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J Clin Microbiol (2001) 0.98
Potential animal and environmental sources of Q fever infection for humans in Queensland. Zoonoses Public Health (2013) 0.97
Delta hepatitis in homosexual men in the United States. Hepatology (1989) 0.97
Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Am J Epidemiol (2005) 0.96
The Australian Measles Control Campaign, 1998. Bull World Health Organ (2001) 0.96
Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev (1993) 0.94
False-negative results in nucleic acid amplification tests-do we need to routinely use two genetic targets in all assays to overcome problems caused by sequence variation? Crit Rev Microbiol (2008) 0.94
Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine (2000) 0.94
Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 0.94
A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatis. Sex Transm Infect (2008) 0.93
Enzyme potentiated radioimmunoassay (EPRIA): a sensitive third-generation test for the detection of hepatitis B surface antigen. J Immunol Methods (1981) 0.93
Persistent non-A, non-B hepatitis in experimentally infected chimpanzees. J Infect Dis (1981) 0.93
Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources. Virology (1998) 0.93
Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection. J Infect Dis (1997) 0.92
Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology (1995) 0.91
A new enzyme immunoassay for the detection of antibody to hepatitis E virus. J Gastroenterol Hepatol (2002) 0.91
In vitro translation of rabies virus messenger RNAs. Virology (1980) 0.91